ELDN (Eledon Pharmaceuticals) Institutional Ownership: 60.45% (As of Jul. 12, 2026)


ELDN Eledon Pharmaceuticals Inc ELDN
27 GF Score
Price $3.85
! 1 Warning Sign
View Full Analysis

What is Eledon Pharmaceuticals Institutional Ownership?

Eledon Pharmaceuticals ELDN -6.78% 27 Institutional Ownership is 60.45% as of Jul. 12, 2026. GuruFocus rates ELDN with a GF Score™ of 27/100. The stock has 1 warning sign investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Eledon Pharmaceuticals's institutional ownership is 60.45%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Eledon Pharmaceuticals's Insider Ownership is 1.24%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Eledon Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 99.97%.

Eledon Pharmaceuticals Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Eledon Pharmaceuticals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eledon Pharmaceuticals Institutional Ownership Chart

Eledon Pharmaceuticals Historical Data

The historical data trend for Eledon Pharmaceuticals can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 18.88 18.86 15.42 16.87 16.70 16.77 18.15 19.16 19.56 20.16
ELDN
27GF Score
Eledon Pharmaceuticals Inc ELDN
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eledon Pharmaceuticals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 60.45% mean?
Eledon Pharmaceuticals (ELDN) has a Institutional Ownership of 60.45% as of Jul. 12, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Eledon Pharmaceuticals and its competitors.
Is Eledon Pharmaceuticals' Institutional Ownership too high?
Eledon Pharmaceuticals' current Institutional Ownership is 60.45%. Overall, Eledon Pharmaceuticals has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Eledon Pharmaceuticals' Institutional Ownership compare to ZNTL and GLSI?
Eledon Pharmaceuticals' Institutional Ownership of 60.45% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Eledon Pharmaceuticals and its competitors. Eledon Pharmaceuticals's current Institutional Ownership is 60.45%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eledon Pharmaceuticals stock overvalued right now?
Eledon Pharmaceuticals (ELDN) has a current Institutional Ownership of 60.45%. The current Institutional Ownership is 60.45%. Eledon Pharmaceuticals' overall GF Score™ is 27/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Eledon Pharmaceuticals (ELDN), the current Institutional Ownership is 60.45% as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Eledon Pharmaceuticals Business Description

Other Exchanges 2TK:Germany
Address 19800 MacArthur Boulevard, Suite 250, Irvine, CA, USA, 92612
Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.
27GF Score

Get the complete analysis for ELDN

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.85
Price